Editorial Policies

You are here: Home / Editorial Policies

Editorial Process

  • All submissions are initially subjected to review by the editorial board and screened for plagiarism.
  • It will be then sent for “Double blinded peer review” to referees in appropriate specialties who have published recently on the subject. We will consider manuscripts for publication from any part of the world, but most particularly manuscripts that would be of interest to readers in the third world.
  • Manuscripts not submitted elsewhere for publication will be considered - Authors must provide an email address as all communication will be by email. Three files must be furnished: The Title page with covering letter, the manuscript in MS Word & author contribution/conflict of interest form. All articles submitted to the Journal must comply with these instructions. Failure to do so will result in return of the manuscript and possible delay in publication.
  • Submission of revised manuscripts - If any changes are made to the manuscript, please mark the changes as underlined or differently colored text in the article. If authors are requested to include a point to point response to reviewer’s comments, they can do so in the correction form template which will be mailed to them.
  • Copyediting - IDMJAR is committed to maintaining a very high quality process of professional scientific copyediting. The copyediting team members strive to produce grammatically accurate and scientifically appropriate content on all IDMJAR PDF’s.
  • Proof Reading - Galley proofs will be sent to the author after the copyediting process is completed. Authors also receive a correction form in which they state the corrections desired, each sentence is numbered in the galley proofs to make the correction process author friendly.
  • Article Withdrawal - If an author decides to withdraw a manuscript prior after proof reading prior to publication then the reasons must be explicitly stated and explained.
  • Retraction of Article - IDMJAR abides by COPE Retraction Guidelines.

Handling submissions from editors, employees, or members of the editorial board to ensure unbiased review

International Dental & Medical Journal of Advanced Research follows a fair process to ensure review of submissions from editors, employees, or members of the editorial board.
On receiving such a manuscript the Editor-in-Chief directly steps in and ensures it is subjected to a double blind peer review process to reviewers unaware of who the authors are vice versa.
On such occasions we seek to add new reviewers to the database or invite external reviewers for such special situations, this ensures ethical handling of manuscripts which may otherwise carry a bias.

IDMJAR Manuscript processing Model
© Image Copyright 2016 International Dental & Medical Journal of Advanced Research. All rights reserved

Conflict of Interest Policy in Publishing

For Authors:

Authors are required to disclose all sources of institutional, private and corporate financial support for their study. Donors of materials (for free or at a discount from current rates) should be named in the source of funding and their location (town, state/county, country) included.
Other donors will be identified in the text. If no funding has been available other than that of the author's institution, this should be specified upon submission. Authors are also required to disclose any potential conflict of interest. These include financial interests (for example patent, ownership, stock ownership, consultancies, speaker's fee,) or provision of study materials by their manufacturer for free or at a discount from current rates.
Author's conflict of interest (or information specifying the absence of conflicts of interest) and the sources of funding for the research will be published under a separate heading entitled “Conflict of Interest and Sources of Funding Statement”.

For Editors:

The editor and any editorial staff must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate.
Disclosure and conflicts of interest unpublished materials disclosed in a submitted paper will not be used by the editor or the members of the editorial board for their own research purposes without the author's explicit written consent.

For Reviewers:

Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions associated with the papers.

View the elaborate Conflict of Interest Policy by clicking here

Human Rights Policy and Patient Consent

International Dental Journal of Advanced Research encourages authors submitting manuscripts reporting from a clinical trial registered & bearing a clinical trial registration number and name of the trial.

Authors must state that the protocol for the research project has been approved by a suitably constituted Ethics Committee of the institution within which the work was undertaken and that it conforms to the provisions of the Declaration of Helsinki.
Available at http://www.wma.net/en/30publications/10policies/b3/

Reports of randomized clinical trials should present information on all major study elements, including the protocol, assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding), based on the CONSORT statement.

All randomized controlled trials submitted for publication should include a completed Consolidated Standards of Reporting Trial flow chart (please go to http://www.consort-statement.org/ for more information). The IDMJAR has adopted the ICMJE proposal that requires, as a condition of consideration for publication of clinical trials, registration in a public trials registry. Trials must register at or before the onset of patient enrolment. The clinical trial registration number should be included at the end of the abstract of the article.

For this purpose, a clinical trial is defined as any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects of health outcomes. Health-related interventions include any intervention used to modify a biomedical or health-related outcome (for example drugs, surgical procedures, devices, behavioral treatments, dietary interventions and process-of-care changes). Health outcomes include any biomedical or health-related measures obtained in patient’s participants, including pharmacokinetic measures and adverse events.

Purely observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) will not require registration. Further information can be found at www.icmje.org

Moher D, Schulz KF, Altman DG: The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials. Ann Intern Med. 2001; 134:657-662 Available at http://www.nlm.nih.gov/mesh/meshhome.html

Consent for Identifying Information

All investigations on human subjects must include a statement that the subject gave informed consent. Authors are required to fill the form on Informed Consent form for participation in Study (Click here to download the form)

Patient anonymity should be preserved. Photographs need to be cropped sufficiently to prevent human subjects being recognized or an eye bar should be used. Authors are required to fill the form on Informed Consent form for use of patient pictures (Click here to download the form)

Animal Rights Policy

Any experiments involving animals must be demonstrated to be ethically acceptable and where relevant conform to national guidelines for animal usage in research. The Journal retains the right to reject any manuscript on the basis of unethical conduct of animal studies.

Studies covering the use of animal samples in research or animal experiments must be accompanied by a letter of approval from the appropriate Institutional Review Board or Animal Ethical Board committee.

When reporting experiments on animals, authors should indicate whether institutional and national standards for the care and use of laboratory animals were followed. The ethical standards of experiments must be in accordance with the guidelines provided by the CPCSEA http://cpcsea.nic.in/Auth/index.aspx

Further guidance on animal research ethics is available from the International Association of Veterinary Editors’ Consensus Author Guidelines on Animal Ethics and Welfare http://www.veteditors.org/consensus-author-guidelines-on-animal-ethics-and-welfare-for-editors/